Patents by Inventor Marco Sardina

Marco Sardina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition containing budesonide and formoterol
    Patent number: 10449147
    Abstract: The present invention relates to inhalation formulations of drugs in the form of dry powder for inhalation administration, suitable for the treatment of obstructive diseases of the airways, such as asthma and chronic obstructive pulmonary disease (COPD).
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: October 22, 2019
    Assignee: Zambon S.P.A.
    Inventors: Loretta Maggi, Giovanni Caponetti, Marco Sardina, Franco Castegini
  • Pharmaceutical composition containing budesonide and formoterol
    Patent number: 10226421
    Abstract: The present invention relates to drug formulations in dry powder form for administration by inhalation and indicated for the treatment of obstructive airway syndromes such as asthma and chronic obstructive pulmonary disease (COPD).
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: March 12, 2019
    Assignee: Zambon S.P.A.
    Inventors: Giovanni Caponetti, Loretta Maggi, Marco Sardina, Franco Castegini, Gianluigi Faiella, Daniela Rebolini
  • PHARMACEUTICAL COMPOSITION CONTAINING BUDESONIDE AND FORMOTEROL
    Publication number: 20170326067
    Abstract: The present invention relates to inhalation formulations of drugs in the form of dry powder for inhalation administration, suitable for the treatment of obstructive diseases of the airways, such as asthma and chronic obstructive pulmonary disease (COPD).
    Type: Application
    Filed: October 7, 2015
    Publication date: November 16, 2017
    Inventors: Loretta MAGGI, Giovanni CAPONETTI, Marco SARDINA, Franco CASTEGINI
  • A PHARMACEUTICAL COMPOSITION CONTAINING BUDESONIDE AND FORMOTEROL
    Publication number: 20160081925
    Abstract: The present invention relates to drug formulations in dry powder form for administration by inhalation and indicated for the treatment of obstructive airway syndromes such as asthma and chronic obstructive pulmonary disease (COPD).
    Type: Application
    Filed: April 9, 2014
    Publication date: March 24, 2016
    Applicant: Zambon S.P.A.
    Inventors: Giovanni Caponetti, Loretta Maggi, Marco Sardina, Franco Castegini, Gianluigi Faiella, Daniela Rebolini